Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Aceso Life Science Group Limited ( (HK:0474) ).
Aceso Life Science Group Limited announced the completion of a deemed disposal transaction following the placement of new shares by its non-wholly-owned subsidiary, HTICI. This transaction resulted in the dilution of Aceso’s shareholding in HTICI from 29.05% to 28.58%, leading to HTICI no longer being a subsidiary. Consequently, HTICI’s results will not be consolidated in Aceso’s financial statements but will be accounted for as an interest in an associate, allowing Aceso to continue benefiting from HTICI’s net assets and operating results.
More about Aceso Life Science Group Limited
Aceso Life Science Group Limited is a company incorporated in the Cayman Islands, operating within the life sciences industry. It focuses on the development and management of life science-related products and services.
Average Trading Volume: 529,101
Technical Sentiment Signal: Sell
Current Market Cap: HK$177.2M
For an in-depth examination of 0474 stock, go to TipRanks’ Stock Analysis page.